Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiandong Gao

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
BMC Complementary and Alternative Medicine|October 23, 2015
Icariin protects rats against 5/6 nephrectomy-induced chronic kidney failure by increasing the number of renal stem cellsZhongdi Huang, Liqun He, Di Huang, et al.
Sleep Medicine|February 22, 2023
Relative spectral power quantifying the distribution of intermittent hypoxemia in obstructive sleep apnea is strongly associated with hypertensionJingyuan You, Jiandong Gao, Mu He, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|March 5, 2025
Noninvasive detection of diabetes in obstructive sleep apnea based on overnight SpO<sub>2</sub> signal and deep learningJingyuan You, Juan Li, Ruijie Yao, et al.
Trials|August 9, 2019
Yinang formulation versus placebo granules as a treatment for chronic kidney disease stages III-IV in patients with autosomal dominant polycystic kidney disease: study protocol for a double-blind placebo-controlled randomized clinical trialJing Gan, Yansheng Wu, Xuezhong Gong, et al.
Pharmaceutical Biology|May 19, 2022
Calycosin plays a protective role in diabetic kidney disease through the regulation of ferroptosisDi Huang, Peicheng Shen, Chen Wang, et al.
Bioorganic Chemistry|March 15, 2025
Jiangniaosuan formula inhibits hyperuricemia-induced apoptosis of renal tubular epithelial cells via ROS/HIF-1α/EZH2 pathway: A network pharmacology analysis and experimental validationJiabao Zhou, Feng Yang, Xuming Zhang, et al.
Trials|January 4, 2022
Efficacy of Chinese herbal medicine Jiangniaosuan formula for treatment of hyperuricemia: study protocol for a double-blinded non-inferiority randomized controlled clinical trialYafang Guo, Hong Lu, Jing Gan, et al.
Journal of Ethnopharmacology|June 11, 2025
Shizhifang alleviates hyperuricemia -induced renal injury by inhibiting Drp1 and maintaining mitochondrial homeostasis in renal tubular epithelial cellsZhiyuan Wu, Yi Zhou, Feng Yang, et al.
Trials|April 16, 2022
Effect of Baihu and Guizhi decoction in acute gouty arthritis: study protocol for a randomized controlled trialYikun He, Chaoran Dai, Jiaying Shen, et al.
Renal Failure|July 15, 2022
TNF-α-mediated podocyte injury via the apoptotic death receptor pathway in a mouse model of IgA nephropathyQiang Wan, Jiabao Zhou, Yansheng Wu, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
BMC Complementary and Alternative Medicine|October 23, 2015
Icariin protects rats against 5/6 nephrectomy-induced chronic kidney failure by increasing the number of renal stem cellsZhongdi Huang, Liqun He, Di Huang, et al.
Sleep Medicine|February 22, 2023
Relative spectral power quantifying the distribution of intermittent hypoxemia in obstructive sleep apnea is strongly associated with hypertensionJingyuan You, Jiandong Gao, Mu He, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|March 5, 2025
Noninvasive detection of diabetes in obstructive sleep apnea based on overnight SpO<sub>2</sub> signal and deep learningJingyuan You, Juan Li, Ruijie Yao, et al.
Trials|August 9, 2019
Yinang formulation versus placebo granules as a treatment for chronic kidney disease stages III-IV in patients with autosomal dominant polycystic kidney disease: study protocol for a double-blind placebo-controlled randomized clinical trialJing Gan, Yansheng Wu, Xuezhong Gong, et al.
Pharmaceutical Biology|May 19, 2022
Calycosin plays a protective role in diabetic kidney disease through the regulation of ferroptosisDi Huang, Peicheng Shen, Chen Wang, et al.
Bioorganic Chemistry|March 15, 2025
Jiangniaosuan formula inhibits hyperuricemia-induced apoptosis of renal tubular epithelial cells via ROS/HIF-1α/EZH2 pathway: A network pharmacology analysis and experimental validationJiabao Zhou, Feng Yang, Xuming Zhang, et al.
Trials|January 4, 2022
Efficacy of Chinese herbal medicine Jiangniaosuan formula for treatment of hyperuricemia: study protocol for a double-blinded non-inferiority randomized controlled clinical trialYafang Guo, Hong Lu, Jing Gan, et al.
Journal of Ethnopharmacology|June 11, 2025
Shizhifang alleviates hyperuricemia -induced renal injury by inhibiting Drp1 and maintaining mitochondrial homeostasis in renal tubular epithelial cellsZhiyuan Wu, Yi Zhou, Feng Yang, et al.
Trials|April 16, 2022
Effect of Baihu and Guizhi decoction in acute gouty arthritis: study protocol for a randomized controlled trialYikun He, Chaoran Dai, Jiaying Shen, et al.
Renal Failure|July 15, 2022
TNF-α-mediated podocyte injury via the apoptotic death receptor pathway in a mouse model of IgA nephropathyQiang Wan, Jiabao Zhou, Yansheng Wu, et al.
Pageof 4